Analysts Offer Insights on Healthcare Companies: and Chembio Diagnostics (CEMI)
There’s a lot to be optimistic about in the Healthcare sector as 1 analysts just weighed in on and Chembio Diagnostics (CEMI) with bullish sentiments.
Chembio Diagnostics (CEMI)
Colliers Securities analyst Kyle Bauser reiterated a Buy rating on Chembio Diagnostics on January 14 and set a price target of $8.00. The company’s shares closed last Wednesday at $4.70.
According to TipRanks.com, Bauser is a 4-star analyst with an average return of 21.0% and a 53.3% success rate. Bauser covers the Healthcare sector, focusing on stocks such as Tactile Systems Technology, Inspire Medical Systems, and Bioanalytical Systems.
Currently, the analyst consensus on Chembio Diagnostics is a Moderate Buy with an average price target of $8.00.
See today’s analyst top recommended stocks >>
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.